Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands |
Total |
Total Shareholders’ Equity Attributable to The Vita Coco Company, Inc. |
Common Stock |
Additional Paid-in Capital |
Retained Earnings |
Accumulated Other Comprehensive Income / (Loss) |
Treasury Stock |
Common Stock
Common Stock
|
Common Stock with Exit Warrants
Common Stock
|
| Beginning balance, common stock (in shares) at Dec. 31, 2024 |
|
|
63,702,387
|
|
|
|
|
55,589,282
|
8,113,105
|
| Beginning balance at Dec. 31, 2024 |
|
$ 258,817
|
$ 637
|
$ 174,077
|
$ 156,694
|
$ (860)
|
$ (71,731)
|
$ 556
|
$ 81
|
| Beginning balance, treasury stock (in shares) at Dec. 31, 2024 |
|
|
|
|
|
|
6,740,446
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Net income attributable to The Vita Coco Company, Inc. |
|
18,882
|
|
|
18,882
|
|
|
|
|
| Purchase of treasury stock (in shares) |
|
|
|
|
|
|
48,973
|
|
|
| Purchase of treasury stock |
|
(1,501)
|
|
|
|
|
$ (1,501)
|
|
|
| Stock-based compensation |
|
2,186
|
|
2,186
|
|
|
|
|
|
| Exercised (in shares) |
|
|
105,332
|
|
|
|
|
105,332
|
|
| Exercise of stock awards |
|
(1,021)
|
$ 1
|
(1,022)
|
|
|
|
$ 1
|
|
| Foreign currency translation adjustment |
|
495
|
|
|
|
495
|
|
|
|
| Ending balance, common stock (in shares) at Mar. 31, 2025 |
|
|
63,807,719
|
|
|
|
|
55,694,614
|
8,113,105
|
| Ending balance at Mar. 31, 2025 |
|
277,858
|
$ 638
|
175,241
|
175,576
|
(365)
|
$ (73,232)
|
$ 557
|
$ 81
|
| Ending balance, treasury stock (in shares) at Mar. 31, 2025 |
|
|
|
|
|
|
6,789,419
|
|
|
| Beginning balance, common stock (in shares) at Dec. 31, 2024 |
|
|
63,702,387
|
|
|
|
|
55,589,282
|
8,113,105
|
| Beginning balance at Dec. 31, 2024 |
|
258,817
|
$ 637
|
174,077
|
156,694
|
(860)
|
$ (71,731)
|
$ 556
|
$ 81
|
| Beginning balance, treasury stock (in shares) at Dec. 31, 2024 |
|
|
|
|
|
|
6,740,446
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Net income attributable to The Vita Coco Company, Inc. |
$ 41,790
|
|
|
|
|
|
|
|
|
| Ending balance, common stock (in shares) at Jun. 30, 2025 |
|
|
63,877,128
|
|
|
|
|
55,764,023
|
8,113,105
|
| Ending balance at Jun. 30, 2025 |
|
296,939
|
$ 639
|
178,774
|
198,484
|
826
|
$ (81,784)
|
$ 558
|
$ 81
|
| Ending balance, treasury stock (in shares) at Jun. 30, 2025 |
|
|
|
|
|
|
7,074,147
|
|
|
| Beginning balance, common stock (in shares) at Dec. 31, 2024 |
|
|
63,702,387
|
|
|
|
|
55,589,282
|
8,113,105
|
| Beginning balance at Dec. 31, 2024 |
|
258,817
|
$ 637
|
174,077
|
156,694
|
(860)
|
$ (71,731)
|
$ 556
|
$ 81
|
| Beginning balance, treasury stock (in shares) at Dec. 31, 2024 |
|
|
|
|
|
|
6,740,446
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Purchase of treasury stock (in shares) |
|
|
363,930
|
|
|
|
|
|
|
| Ending balance, common stock (in shares) at Dec. 31, 2025 |
57,082,173
|
|
64,186,549
|
|
|
|
|
56,073,444
|
8,113,105
|
| Ending balance at Dec. 31, 2025 |
$ 331,542
|
331,542
|
$ 642
|
185,400
|
228,014
|
486
|
$ (83,000)
|
$ 561
|
$ 81
|
| Ending balance, treasury stock (in shares) at Dec. 31, 2025 |
7,104,376
|
|
|
|
|
|
7,104,376
|
|
|
| Beginning balance, common stock (in shares) at Mar. 31, 2025 |
|
|
63,807,719
|
|
|
|
|
55,694,614
|
8,113,105
|
| Beginning balance at Mar. 31, 2025 |
|
277,858
|
$ 638
|
175,241
|
175,576
|
(365)
|
$ (73,232)
|
$ 557
|
$ 81
|
| Beginning balance, treasury stock (in shares) at Mar. 31, 2025 |
|
|
|
|
|
|
6,789,419
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Net income attributable to The Vita Coco Company, Inc. |
$ 22,908
|
22,908
|
|
|
22,908
|
|
|
|
|
| Purchase of treasury stock (in shares) |
|
|
|
|
|
|
284,728
|
|
|
| Purchase of treasury stock |
|
(8,552)
|
|
|
|
|
$ (8,552)
|
|
|
| Stock-based compensation |
|
2,962
|
|
2,962
|
|
|
|
|
|
| Exercised (in shares) |
|
|
69,409
|
|
|
|
|
69,409
|
|
| Exercise of stock awards |
|
572
|
$ 1
|
571
|
|
|
|
$ 1
|
|
| Foreign currency translation adjustment |
|
1,191
|
|
|
|
1,191
|
|
|
|
| Ending balance, common stock (in shares) at Jun. 30, 2025 |
|
|
63,877,128
|
|
|
|
|
55,764,023
|
8,113,105
|
| Ending balance at Jun. 30, 2025 |
|
296,939
|
$ 639
|
178,774
|
198,484
|
826
|
$ (81,784)
|
$ 558
|
$ 81
|
| Ending balance, treasury stock (in shares) at Jun. 30, 2025 |
|
|
|
|
|
|
7,074,147
|
|
|
| Beginning balance, common stock (in shares) at Dec. 31, 2025 |
57,082,173
|
|
64,186,549
|
|
|
|
|
56,073,444
|
8,113,105
|
| Beginning balance at Dec. 31, 2025 |
$ 331,542
|
331,542
|
$ 642
|
185,400
|
228,014
|
486
|
$ (83,000)
|
$ 561
|
$ 81
|
| Beginning balance, treasury stock (in shares) at Dec. 31, 2025 |
7,104,376
|
|
|
|
|
|
7,104,376
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Net income attributable to The Vita Coco Company, Inc. |
|
30,474
|
|
|
30,474
|
|
|
|
|
| Purchase of treasury stock (in shares) |
|
|
|
|
|
|
225,273
|
|
|
| Purchase of treasury stock |
|
(11,505)
|
|
|
|
|
$ (11,505)
|
|
|
| Stock-based compensation |
|
4,626
|
|
4,626
|
|
|
|
|
|
| Exercised (in shares) |
|
|
249,405
|
|
|
|
|
249,405
|
|
| Exercise of stock awards |
|
(2,504)
|
$ 2
|
(2,506)
|
|
|
|
$ 2
|
|
| Foreign currency translation adjustment |
|
(460)
|
|
|
|
(460)
|
|
|
|
| Ending balance, common stock (in shares) at Mar. 31, 2026 |
|
|
64,435,954
|
|
|
|
|
56,322,849
|
8,113,105
|
| Ending balance at Mar. 31, 2026 |
|
352,173
|
$ 644
|
187,520
|
258,488
|
26
|
$ (94,505)
|
$ 563
|
$ 81
|
| Ending balance, treasury stock (in shares) at Mar. 31, 2026 |
|
|
|
|
|
|
7,329,649
|
|
|
| Beginning balance, common stock (in shares) at Dec. 31, 2025 |
57,082,173
|
|
64,186,549
|
|
|
|
|
56,073,444
|
8,113,105
|
| Beginning balance at Dec. 31, 2025 |
$ 331,542
|
331,542
|
$ 642
|
185,400
|
228,014
|
486
|
$ (83,000)
|
$ 561
|
$ 81
|
| Beginning balance, treasury stock (in shares) at Dec. 31, 2025 |
7,104,376
|
|
|
|
|
|
7,104,376
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Net income attributable to The Vita Coco Company, Inc. |
$ 79,925
|
|
|
|
|
|
|
|
|
| Purchase of treasury stock (in shares) |
|
|
398,891
|
|
|
|
|
|
|
| Ending balance, common stock (in shares) at Jun. 30, 2026 |
57,397,082
|
|
64,900,349
|
|
|
|
|
56,787,244
|
8,113,105
|
| Ending balance at Jun. 30, 2026 |
$ 400,904
|
400,904
|
$ 649
|
195,611
|
307,939
|
(287)
|
$ (103,008)
|
$ 568
|
$ 81
|
| Ending balance, treasury stock (in shares) at Jun. 30, 2026 |
7,503,267
|
|
|
|
|
|
7,503,267
|
|
|
| Beginning balance, common stock (in shares) at Mar. 31, 2026 |
|
|
64,435,954
|
|
|
|
|
56,322,849
|
8,113,105
|
| Beginning balance at Mar. 31, 2026 |
|
352,173
|
$ 644
|
187,520
|
258,488
|
26
|
$ (94,505)
|
$ 563
|
$ 81
|
| Beginning balance, treasury stock (in shares) at Mar. 31, 2026 |
|
|
|
|
|
|
7,329,649
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Net income attributable to The Vita Coco Company, Inc. |
$ 49,451
|
49,451
|
|
|
49,451
|
|
|
|
|
| Purchase of treasury stock (in shares) |
|
|
173,618
|
|
|
|
173,618
|
|
|
| Purchase of treasury stock |
|
(8,503)
|
|
|
|
|
$ (8,503)
|
|
|
| Stock-based compensation |
|
3,590
|
|
3,590
|
|
|
|
|
|
| Exercised (in shares) |
|
|
464,395
|
|
|
|
|
464,395
|
|
| Exercise of stock awards |
|
4,506
|
$ 5
|
4,501
|
|
|
|
$ 5
|
|
| Foreign currency translation adjustment |
|
(313)
|
|
|
|
(313)
|
|
|
|
| Ending balance, common stock (in shares) at Jun. 30, 2026 |
57,397,082
|
|
64,900,349
|
|
|
|
|
56,787,244
|
8,113,105
|
| Ending balance at Jun. 30, 2026 |
$ 400,904
|
$ 400,904
|
$ 649
|
$ 195,611
|
$ 307,939
|
$ (287)
|
$ (103,008)
|
$ 568
|
$ 81
|
| Ending balance, treasury stock (in shares) at Jun. 30, 2026 |
7,503,267
|
|
|
|
|
|
7,503,267
|
|
|